Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Damon Runyon-Dale F. Frey Award for Breakthrough Scientists Overview

Damon Runyon Cancer Research Foundation

The Damon Runyon Fellowship identifies the nation’s top postdoctoral fellows and provides funding that enables them to complete their training under the mentorship of a leading senior scientist and encourages them to follow their own bold ideas. At the end of the Fellowship, there are often a select few who have greatly exceeded the Foundation’s highest expectations. These spectacular young scientists are the most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer. To catapult their research careers—and their impact on cancer—the Foundation will make an additional investment in these exceptional individuals by selecting them as recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists.

In doing so, the Foundation will:

Provide additional financial support to enable these scientists to continue the pursuit of bold and innovative ideas
Accelerate the path to independence
Encourage a continued career in cancer research

Selection and Review

The Fellowship Award Committee will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation’s Board of Directors.

The primary criteria used to evaluate applicants are:

Exceptional productivity and significant accomplishments during the Damon Runyon Fellowship
Potential of the applicant to become a leader in the field of cancer research
Potential of the research to impact the prevention, diagnosis, or treatment of one or more forms of cancer

At the beginning of each review session, the following statement is read aloud:

As an organization, the Damon Runyon Cancer Research Foundation has an uncompromising commitment to excellence and values diversity, equity, and inclusion in all of its Award Programs. The Foundation seeks to promote gender equality and increase diversity, in all of its forms, throughout our programs. Studies have demonstrated that often subtle and unconscious biases can dramatically affect outcomes in review processes and that by simply acknowledging that unconscious biases exist, we can combat their potential negative impact. To that end, please be aware of your potential unconscious biases when reviewing, scoring and discussing candidates and applications throughout the review process.

Funding

The award is $100,000 paid over one year and should be expended within two years of the initial award date.
All awards will be made to the host institution for the support of the designated investigator.
The funds are intended to be flexible and can be used for a variety of scientific needs including the awardee’s salary, salaries for professional and technical personnel, equipment, supplies, and other miscellaneous items required to conduct the research. Funds may also be used to defray the cost of the recipient’s healthcare benefits.
Should the awardee move to an independent position at another institution during the award period, the funds may be transferred to the new institution.
The award cannot be used for indirect costs or institutional overhead.

Deadline Date	Award Selection Dates	DRG/DRQ
July 15, 2025	November 2021, May 2022, and February 2023	DRG-2454-22 to DRG-2482-22, DRQ-16-23 to DRQ-18-23

Specialties

Cancer

Eligibility Requirements

Damon Runyon Fellows are eligible to apply in the last year of their Fellowship. Currently, Damon Runyon Fellows selected in November 2021, May 2022, and February 2023 (DRG-2454-22 to DRG-2482-22, DRQ-16-23 to DRQ-18-23) are eligible to apply.
› Fellows who have terminated their awards early to accept an independent academic faculty position or other funding are eligible.
› Fellows who have moved to a position at a for-profit organization are not eligible.

Fellows may only apply once, at the deadline date that correlates with their award selection date.

Sponsor Details

Sponsor Institute/Organizations: Damon Runyon Cancer Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: One Exchange Plaza 55 Broadway, Suite 302 New York, NY 10006

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity